Biagio Ricciuti: How Can Biomarkers Predict Response to PD-(L)1 Blockade in Lung Cancer?
Biagio Ricciuti/LinkedIn

Biagio Ricciuti: How Can Biomarkers Predict Response to PD-(L)1 Blockade in Lung Cancer?

Biagio Ricciuti, Thoracic Medical Oncologist at Dana-Farber Cancer Institute, shared on LinkedIn:

“Great presentations at the Harvard Lung Cancer Symposium from our terrific research group, showcasing their efforts to identify biomarkers of response and resistance to PD-(L)1 blockade in both metastatic and early-stage lung cancer!

Very proud of the work our fellows Edoardo Garbo, Cassio Murilo Hidalgo Filho, Leonardo Brunetti are doing to advance our understanding of lung cancer immunotherapy.

I feel incredibly fortunate to work alongside such a talented, dedicated, and compassionate team!”

Biagio Ricciuti: How Can Biomarkers Predict Response to PD-(L)1 Blockade in Lung Cancer?

You can also read: